Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
出版年份 2020 全文链接
标题
Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data
作者
关键词
-
出版物
Therapeutic Advances in Psychopharmacology
Volume 10, Issue -, Pages 204512532090575
出版商
SAGE Publications
发表日期
2020-02-12
DOI
10.1177/2045125320905752
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
- (2019) Willie Earley et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mixed mood states: Baffled, bewildered, befuddled and bemused
- (2019) Stephen M. Stahl et al. BIPOLAR DISORDERS
- Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone
- (2019) Filippo Corponi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine
- (2019) Béla Kiss et al. Drug Design Development and Therapy
- Cariprazine in the treatment of Bipolar Disorder: A systematic review and meta‐analysis
- (2019) Jairo Vinícius Pinto et al. BIPOLAR DISORDERS
- Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
- (2019) Roger S. McIntyre et al. CNS SPECTRUMS
- Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials
- (2019) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
- (2018) Lakshmi N Yatham et al. BIPOLAR DISORDERS
- The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study
- (2018) Terence A. Ketter et al. JOURNAL OF AFFECTIVE DISORDERS
- Cariprazine In Bipolar Depression And Mania: State Of The Art
- (2018) Marianna Mazza et al. CNS & Neurological Disorders-Drug Targets
- Efficacy of adjunctive low-dose cariprazine in major depressive disorder
- (2018) Maurizio Fava et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine specificity profile in the treatment of acute schizophrenia
- (2017) Filippo Corponi et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model
- (2017) Vanja Duric et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
- (2017) Heinz Grunze et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
- (2016) Suresh Durgam et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mechanism of action of cariprazine
- (2016) Stephen M. Stahl CNS SPECTRUMS
- The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders
- (2016) Domenico Berardis et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
- (2016) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
- (2015) Gary S. Sachs et al. JOURNAL OF AFFECTIVE DISORDERS
- The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
- (2014) Suresh Durgam et al. BIPOLAR DISORDERS
- Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder
- (2014) Joseph R. Calabrese et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dopamine D3 receptor as a new pharmacological target for the treatment of depression
- (2013) Gian Marco Leggio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A proposal for an updated neuropsychopharmacological nomenclature
- (2013) Joseph Zohar et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
- (2013) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse
- (2012) Ross Zimnisky et al. PSYCHOPHARMACOLOGY
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now